162 related articles for article (PubMed ID: 8273367)
1. [Interferon-alpha therapy in non-Hodgkin's lymphoma].
Fridrik MA
Wien Med Wochenschr; 1993; 143(16-17):429-34. PubMed ID: 8273367
[TBL] [Abstract][Full Text] [Related]
2. Innovative treatment strategies for non-Hodgkin's lymphoma and multiple myeloma.
Borden EC
Semin Oncol; 1994 Dec; 21(6 Suppl 14):14-22. PubMed ID: 7992095
[TBL] [Abstract][Full Text] [Related]
3. Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.
Zinzani PL; Levrero MG; Lauria F; Rondelli D; Zaja F; Russo D; Fanin R; De Rossi G; Mauro FR; Bendandi M; Gozzetti A; Dianzani F; Mandelli F; Tura S
Haematologica; 1994; 79(1):55-60. PubMed ID: 15378949
[TBL] [Abstract][Full Text] [Related]
4. High dose alpha-2-recombinant interferon in the treatment of malignant lymphoproliferative diseases. A pilot study.
Opat P; Drbal J; Vyzula R
Neoplasma; 1989; 36(4):489-94. PubMed ID: 2770934
[TBL] [Abstract][Full Text] [Related]
5. Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.
Tsimberidou AM; Giles F; Romaguera J; Duvic M; Kurzrock R
Cancer; 2004 Feb; 100(3):574-80. PubMed ID: 14745875
[TBL] [Abstract][Full Text] [Related]
6. [The therapeutic effect of interferon-alpha exemplified by hairy cell leukemia].
Schwarzmeier JD
Wien Med Wochenschr; 1993; 143(16-17):412-5. PubMed ID: 8273363
[TBL] [Abstract][Full Text] [Related]
7. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
8. [Non-Hodgkin's lymphoma: unusual testicular localization: case report].
Vanhooren A; Delwiche F; Wart F
Acta Urol Belg; 1993 Sep; 61(3):39-42. PubMed ID: 8256686
[TBL] [Abstract][Full Text] [Related]
9. NCCN: Non-Hodgkin's lymphoma.
Zelenetz AD; Hoppe RT;
Cancer Control; 2001; 8(6 Suppl 2):102-13. PubMed ID: 11760551
[No Abstract] [Full Text] [Related]
10. High rates of long-lasting remissions after 5-day bendamustine chemotherapy cycles in pre-treated low-grade non-Hodgkin's-lymphomas.
Bremer K
J Cancer Res Clin Oncol; 2002 Nov; 128(11):603-9. PubMed ID: 12458340
[TBL] [Abstract][Full Text] [Related]
11. [Interferon alpha in the treatment of non-Hodgkin's lymphomas of low malignancy].
Monnereau A; Soubeyran P; Bonichon F; Eghbali H; Tchen N; Hoerni B
Bull Cancer; 1998 Oct; 85(10):855-65. PubMed ID: 9835863
[TBL] [Abstract][Full Text] [Related]
12. [Interferon-alpha in cutaneous T-cell lymphoma].
Knobler R
Wien Med Wochenschr; 1993; 143(16-17):435-7. PubMed ID: 8273368
[TBL] [Abstract][Full Text] [Related]
13. The role of interferon in the therapy of malignant lymphoma.
McLaughlin P
Biomed Pharmacother; 1996; 50(3-4):140-8. PubMed ID: 8881370
[TBL] [Abstract][Full Text] [Related]
14. [Alpha interferon in therapy of non-Hodgkin's lymphoma].
Freund M; Hanauske AR
Onkologie; 1990 Dec; 13(6):424-8. PubMed ID: 2092278
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interferon-alpha therapy in patients with follicular lymphoma.
Ozer H; Wiernik PH; Giles F; Tendler C
Cancer; 1998 May; 82(10):1821-30. PubMed ID: 9587113
[TBL] [Abstract][Full Text] [Related]
16. [Systemic therapy of low malignancy non-Hodgkin lymphomas].
Wörmann B; Buske C; Hiddemann W
Praxis (Bern 1994); 1998 Jun; 87(23):806-11. PubMed ID: 9654987
[TBL] [Abstract][Full Text] [Related]
17. Striking complete remission after interferon-alpha for secondary recurrent non-Hodgkin's lymphoma but rare interferon-induced side effects.
Deschler B; Reincke M; Bley TA; Brink I; Engelhardt M
Ann Hematol; 2005 Apr; 84(4):263-6. PubMed ID: 15004725
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
19. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
20. [Discordant lymphoma: a report of 2 new cases and a review of the literature].
Azaceta Reinares G; Domingo Morera JM; Rabasa Baraibar P; Palomera Bernal L
Rev Clin Esp; 1998 Nov; 198(11):749-51. PubMed ID: 9883049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
